XML 21 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments

A summary of assets and liabilities at June 30, 2019 and December 31, 2018, related to the Company's financial instruments measured at fair value on a recurring basis, is set forth below, along with the balance sheet accounts they are classified within:
 
Balance at June 30, 2019
 
Quoted Prices in Active Markets for Identical Assets
 (Level 1)
 
Significant
Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Cash equivalents
 
 
 
 
 
 
 
        Money market funds
$
195,996

 
$
195,996

 
$

 
$

   U.S. treasury securities
29,940

 

 
29,940

 

Short-term investments
 
 
 
 
 
 
 
   U.S. treasury securities
35,365

 

 
35,365

 

Loans held for sale
30,169

 

 
30,169

 

Prepaid expenses and other current assets
 
 
 
 
 
 
 
Forward sales commitments
25

 

 
25

 

Interest rate lock commitments
712

 

 

 
712

Total prepaid expenses and other current assets
737

 


25

 
712

Long-term investments
 
 
 
 
 
 
 
   U.S. treasury securities
34,954

 

 
34,954

 

Total assets
$
327,161

 
$
195,996

 
$
130,453

 
$
712

Liabilities
 
 
 
 
 
 
 
Accrued liabilities
 
 
 
 
 
 
 
Forward sales commitments
$
407

 
$

 
$
407

 
$

Interest rate lock commitments
24

 

 

 
24

Total liabilities
$
431

 
$

 
$
407

 
$
24


 
Balance at December 31, 2018
 
Quoted Prices in Active Markets for Identical Assets
 (Level 1)
 
Significant
Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
Cash equivalents

 
 
 

 

Money market funds
$
425,776

 
$
425,776

 
$

 
$

Loans held for sale
4,913

 

 
4,913

 

Prepaid expenses and other current assets

 
 
 
 
 
 
Interest rate lock commitments
254

 

 

 
254

Total prepaid expenses and other current assets
254

 



 
254

Total assets
$
430,943

 
$
425,776

 
$
4,913

 
$
254

Liabilities
 
 
 
 
 
 
 
Accrued liabilities
 
 
 
 
 
 
 
Forward sales commitments
$
141

 
$

 
$
141

 
$

Total liabilities
$
141

 
$

 
$
141

 
$


There were no material transfers between levels, and there was no significant activity within Level 3 financial instruments during the periods presented.

See Note 14: Debt for the carrying amount and estimated fair value of the Company's 1.75% Convertible Senior Notes due 2023 (the "Notes").

Assets and liabilities recognized or disclosed at fair value on a nonrecurring basis include items such as property, plant and equipment, goodwill and other intangible assets, cost method investments, and other assets. These assets are measured at fair value if determined to be impaired. The Company did not record any significant nonrecurring fair value measurements after initial recognition for the period ended June 30, 2019.

Gross unrealized holding gains and losses on available-for-sale debt securities were not material as of June 30, 2019.